Table of Contents

Mice Lacking D5 Dopamine Receptors Have Increased Sympathetic Tone and Are Hypertensive

  1. David R. Sibley1
  1. 1Molecular Neuropharmacology Section and
  2. 2Basic Neurosciences Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1406,
  3. 3Department of Pediatrics, Georgetown University Medical Center, Washington, DC 20007,
  4. 4CNS/Cardiovascular Research, Schering-Plough Research Institute, Kenilworth, New Jersey 07033,
  5. 5Department of Neuroscience, The Chicago Medical School, North Chicago, Illinois 60064,
  6. 6Section on Neural Gene Expression, National Institute of Mental Health, Bethesda, Maryland 20892,
  7. 7Institute of Pharmacology and Therapeutics, Faculty of Medicine of Porto, Porto, Portugal, and
  8. 8Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892

Abstract

Dopamine is an important transmitter in the CNS and PNS, critically regulating numerous neuropsychiatric and physiological functions. These actions of dopamine are mediated by five distinct receptor subtypes. Of these receptors, probably the least understood in terms of physiological functions is the D5 receptor subtype. To better understand the role of the D5 dopamine receptor (DAR) in normal physiology and behavior, we have now used gene-targeting technology to create mice that lack this receptor subtype. We find that the D5 receptor-deficient mice are viable and fertile and appear to develop normally. No compensatory alterations in other dopamine receptor subtypes were observed. We find, however, that the mutant mice develop hypertension and exhibit significantly elevated blood pressure (BP) by 3 months of age. This hypertension appears to be caused by increased sympathetic tone, primarily attributable to a CNS defect. Our data further suggest that this defect involves an oxytocin-dependent sensitization of V1 vasopressin and non-NMDA glutamatergic receptor-mediated pathways, potentially within the medulla, leading to increased sympathetic outflow. These results indicate that D5dopamine receptors modulate neuronal pathways regulating blood pressure responses and may provide new insights into mechanisms for some forms of essential hypertension in humans, a disease that afflicts up to 25% of the aged adult population in industrialized societies.

  • Received May 31, 2002.
  • Revision received September 19, 2002.
  • Accepted September 20, 2002.